Stay updated on Safe Doses CX-188 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.

Latest updates to the Safe Doses CX-188 in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section added with Virginia as a listed site. HHS Vulnerability Disclosure and Virginia Locations references were removed; revision updated to v3.3.3.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedFooter Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding lapse notice on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedThe updated page shows a revised layout and minor text reflow while core sections such as Brief Summary, Eligibility Criteria, and Outcome Measures appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference6%

- Check98 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software/version release with no evident changes to core content or functionality.SummaryDifference0.2%

Stay in the know with updates to Safe Doses CX-188 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.